Publication | Closed Access

Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival

Intensified AdjuvantSurgical OncologyModality TherapyMedicineAcceptable ToxicityPathologyCombined Modality TreatmentCancer TreatmentOncologyRadiation Oncology